1. Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain
2. Girona Biomedical Research Institute (IDIBGI), Girona, Spain
3. Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain
4. Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
5. Medical Oncology, Catalan Institute of Oncology, Girona, Spain
6. Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián, Spain
7. Biodonostia Health Research Institute, Donostia-San Sebastián, Spain
8. Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona, Spain
9. IOB Institute of Oncology, Hospital Quirónsalud, Madrid and Barcelona, Spain
10. Medical Oncology Service, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
11. Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain
12. Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
13. Medical Oncology, Hospital Universitari Sant Joan, Reus, Spain
14. Medical Oncology Service, Hospital Universitario Araba, Vitoria-Gasteiz, Spain
15. Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain
16. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
17. Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Barcelona, Spain
18. Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Girona, Spain
19. Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Spain
20. Clinical Research Unit, Catalan Institute of Oncology, L’Hospitalet de Llobregat, Barcelona, Spain
21. Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain